← SynDRA
THONZONIUM
SynDRA canonical compound SYN0023534 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | ATPase inhibitor |
| Indication | ear infections |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- tonzonium
- thonzonium bromide
- tonzonium bromide
- thonzide
- Thonzonium cation
- Thonzonium ion
- Tonzonium
- Z05ZE98FV8
- N-(2-((4-Methoxybenzyl)(pyrimidin-2-yl)amino)ethyl)-N,N-dimethylhexadecan-1-aminium
- NCGC00016507-01
- CAS-553-08-2
- UNII-Z05ZE98FV8
- Thonizide
- Prestwick0_000925
- Prestwick1_000925
- Prestwick2_000925
- Prestwick3_000925
- TONZONIUM [WHO-DD]
- BSPBio_000830
- cid_11102
- SPBio_003009
- BPBio1_000914
- SCHEMBL5990893
- CHEMBL1201322
- DTXSID8048232
- BDBM59083
- CHEBI:94514
- ZINC8035268
- DB09552
- NCGC00016507-02
- NCGC00016507-03
- AB00513967
- AB00513967_12
- AB00513967_13
- Q27166363
- Hexadecyl[2-[(p-methoxybenzyl)-2-pyrimidinylamino]ethyl]dimethylaminium
- hexadecyl-[2-[(4-methoxyphenyl)methyl-(2-pyrimidinyl)amino]ethyl]-dimethylammonium
Reported adverse events
Look up THONZONIUM in the interactive SynDRA portal →